Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES.
| Autor: | Szarek, Michael, Reijnders, Esther, Steg, Ph Gabriel, Jukema, J Wouter, Schwertfeger, Markus, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Fazio, Sergio, Garon, Genevieve, Goodman, Shaun G, Harrington, Robert A, White, Harvey D, Zeiher, Andreas M, Cobbaert, Christa, Schwartz, Gregory G |
|---|---|
| Zdroj: | European Journal of Preventive Cardiology; Aug2024, Vol. 31 Issue 10, pe75-e78, 4p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|